LDN Social Media
Get connected with us on social networks
Endogenous opioids modulate inflammation in the animal model of Multiple Sclerosis - Chirag Patel, MD (2021 Conference) (LDN, low dose naltrexone)
In this presentation, Dr. Patel shares his use of Naltrexone and LDN within his research and what findings they have made. Dr. Patel shares the thesis they started with, the specifics of their studies, and detailed findings that could lead to application for human patients living with MS.
Keywords: Low Dose Naltrexone, LDN, Naltrexone, central nervous system, Multiple Sclerosis, MS, opioids, opioid growth factor, OGF, opioid receptor, experiment, research, autoimmune pathologies, inflammation, autoimmune encephalitis, inflammatory cytokines, blood brain barrier, demyelination, studies, experimental autoimmune encephalomyelitis model
This is a summary of the presentation. Click on the video for full information.